We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNX icon
201
Knight Transportation
KNX
$11.3B
$1.71M 0.1%
35,026
-560
-2% -$28.7K
LQDT icon
202
Liquidity Services
LQDT
$1.27B
$1.69M 0.1%
+104,032
New +$1.83M
AZTA icon
203
Azenta
AZTA
$1.53B
$1.68M 0.1%
39,134
-367
-0.9% -$21.9K
DVN icon
204
Devon Energy
DVN
$49.8B
$1.66M 0.1%
27,626
-636
-2% -$39.5K
ZBH icon
205
Zimmer Biomet
ZBH
$18.5B
$1.66M 0.1%
15,882
-173
-1% -$19K
BWXT icon
206
BWX Technologies
BWXT
$15.5B
$1.64M 0.1%
32,622
-346
-1% -$18.7K
MATX icon
207
Matsons
MATX
$6.24B
$1.63M 0.09%
26,412
-418
-2% -$32.1K
THS
208
DELISTED
Treehouse Foods
THS
$1.59M 0.09%
37,465
-513
-1% -$23K
CSCO icon
209
Cisco
CSCO
$490B
$1.59M 0.09%
39,669
-1,840
-4% -$81.6K
CERT icon
210
Certara
CERT
$1.22B
$1.5M 0.09%
+113,015
New +$2.09M
SSTI icon
211
SoundThinking
SSTI
$104M
$1.49M 0.09%
51,756
-929
-2% -$29.2K
DOV icon
212
Dover
DOV
$28.3B
$1.47M 0.09%
12,637
-205
-2% -$26.2K
ARAY icon
213
Accuray
ARAY
$35.6M
$1.47M 0.08%
704,416
+1,830
+0.3% +$4.16K
HZNP
214
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.42M 0.08%
+22,998
New +$1.61M
BOOM icon
215
DMC Global
BOOM
$155M
$1.38M 0.08%
86,248
+2,721
+3% +$55.2K
NVDA icon
216
NVIDIA
NVDA
$5.3T
$1.36M 0.08%
112,000
-7,690
-6% -$122K
CIEN icon
217
Ciena
CIEN
$56.3B
$1.35M 0.08%
33,395
-457
-1% -$22K
GBCI icon
218
Glacier Bancorp
GBCI
$6.33B
$1.34M 0.08%
27,366
-357
-1% -$18K
CDW icon
219
CDW
CDW
$17.1B
$1.33M 0.08%
8,553
-396
-4% -$67.9K
CODA icon
220
Coda Octopus Group
CODA
$119M
$1.31M 0.08%
242,698
+1,530
+0.6% +$7.68K
YMAB
221
DELISTED
Y-mAbs Therapeutics
YMAB
$1.31M 0.08%
90,665
-1,233
-1% -$20.4K
DLB icon
222
Dolby
DLB
$5.83B
$1.3M 0.08%
19,893
-231
-1% -$17.2K
EXEL icon
223
Exelixis
EXEL
$13.1B
$1.29M 0.07%
81,991
-5,595
-6% -$108K
MP icon
224
MP Materials
MP
$9.75B
$1.25M 0.07%
45,945
-466
-1% -$15.2K
EBAY icon
225
eBay
EBAY
$48.5B
$1.17M 0.07%
31,644
-392
-1% -$17.5K

Similar funds

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.